Varex Imaging Corp Stock News

VREX earnings call for the period ending December 31, 2021.

VREX earnings call for the period ending December 31, 2021.

Varex Imaging Corporation (NASDAQ:VREX) Q1 2022 Earnings Conference Call February 8, 2022 5:00 PM ET Company Participants Christopher Belfiore – Director-Investor Relations Sunny Sanyal –…

Varex Imaging press release (NASDAQ:VREX): FQ1 Non-GAAP EPS of $0.25 misses by $0.03.Revenue of $198.8M (+12.3% Y/Y) misses by $9.47M.Shares -4.64%.

Varex Imaging's (VREX) CEO Sunny Sanyal on Q1 2022 Results - Earnings Call Transcript

Varex Imaging (NASDAQ:VREX) is scheduled to announce Q1 earnings results on Tuesday, February 8th, after market close.The consensus EPS Estimate is $0.28 (+250.0% Y/Y) and the

Varex Imaging Corp (VREX) shares closed today at 1.0% below its 52 week high of $32.44, giving the company a market cap of $1B. The stock is currently up 94.3% year-to-date, up 102.9% over the past 12 months, and up 18.8% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 47.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 470.5% The company's stock price performance over the past 12 months beats the peer average by 482.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 300.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Varex Imaging Corp (VREX) shares closed 0.9% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 91.3% year-to-date, up 97.6% over the past 12 months, and up 17.0% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 47.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 463.6% The company's stock price performance over the past 12 months beats the peer average by 520.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 300.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Varex Imaging Corp (VREX) shares closed 1.5% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 86.8% year-to-date, up 90.8% over the past 12 months, and up 14.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 6.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 391.3% The company's stock price performance over the past 12 months beats the peer average by 495.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 300.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Varex Imaging Corp (VREX) shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 80.3% year-to-date, up 83.6% over the past 12 months, and up 10.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 158.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 416.5% The company's stock price performance over the past 12 months beats the peer average by 526.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 300.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zimmer Biomet (ZBH) continues to face COVID-induced challenges and market pressure.

Investors are optimistic about Alcon's (ALC) better-than-expected third-quarter results and robust performance by the Vision Care arm.

Avantor's (AVTR) new logistics hub in Westminster is intended to support growth of single-use businesses.

Investors are optimistic about NEOGEN (NEOG) given robust sales growth in the Food Safety business and impressive international performance.

The company is recovering from the steep losses it experienced during the height of the COVID-19 pandemic.